Literature DB >> 14703105

Morphological and functional changes of human vocal fold fibroblasts with hepatocyte growth factor.

Shigeru Hirano1, Diane M Bless, Randall J Massey, Gregory K Hartig, Charles N Ford.   

Abstract

Fibroblasts produce extracellular matrix and play an important role in wound healing and scarring. Hepatocyte growth factor (HGF) has strong antifibrotic activity, and has been suggested to have therapeutic potential for treatment of fibrotic diseases. In the present in vitro study, morphological and functional changes of human vocal fold fibroblasts with HGF were examined by transmission electron microscopy and enzyme-linked immunosorbent assay to help clarify the potential use of HGF in the prevention or treatment of vocal fold scarring. The HGF stimulated the production of hyaluronic acid (HA) and decreased the production of collagen type I from the fibroblasts in Reinke's space (FbRS), whereas fibronectin production was not affected. The HGF also changed the shape of the FbRS from an oval shape toward a spindle and stellate shape, and developed Golgi apparatus (GA) and rough endoplasmic reticulum (rER) in the FbRS. The fibroblasts in the macula flava (FbMF) presented with much more production of HA and collagen type I than did FbRS, and were more frequently formed in a stellate shape with well-developed GA and rER. The HGF decreased the production of collagen type I from the FbMF, but barely affected the FbMF in terms of the shape of the cells, the development of GA and rER, or the production of HA. These results were interpreted to suggest that the FbMF are not as susceptible to HGF as are FbRS. On the contrary, HGF appeared to activate the FbRS and modify the function. The increased HA and decreased collagen type I production from the FbRS suggest that HGF may be useful in the prevention or treatment of fibrotic vocal fold scarring.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14703105     DOI: 10.1177/000348940311201206

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  6 in total

1.  [Treatment of glottal gap].

Authors:  S Voigt-Zimmermann; C Arens
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

2.  Prostaglandin (PG)E2 exhibits antifibrotic activity in vocal fold fibroblasts.

Authors:  Hang Zhou; Diane Felsen; Vlad C Sandulache; Milan R Amin; Dennis H Kraus; Ryan C Branski
Journal:  Laryngoscope       Date:  2011-05-06       Impact factor: 3.325

3.  Functional morphology of the sound-generating labia in the syrinx of two songbird species.

Authors:  Tobias Riede; Franz Goller
Journal:  J Anat       Date:  2009-11-09       Impact factor: 2.610

4.  Advances in biomimetic regeneration of elastic matrix structures.

Authors:  Balakrishnan Sivaraman; Chris A Bashur; Anand Ramamurthi
Journal:  Drug Deliv Transl Res       Date:  2012-10       Impact factor: 4.617

5.  Controlled release of hepatocyte growth factor from a bovine acellular scaffold for vocal fold reconstruction.

Authors:  Chet C Xu; Roger W Chan; Debra G Weinberger; Guy Efune; Karen S Pawlowski
Journal:  J Biomed Mater Res A       Date:  2010-06-15       Impact factor: 4.396

6.  Reinke's edema: investigations on the role of MIB-1 and hepatocyte growth factor.

Authors:  M Artico; E Bronzetti; B Ionta; M Bruno; A Greco; G Ruoppolo; A De Virgilio; L Longo; M De Vincentiis
Journal:  Eur J Histochem       Date:  2010-07-08       Impact factor: 3.188

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.